Coriene Catsman-Berrevoets is a Paediatric Neurologist. She is working at the ErasmusMC / Sophia Children’s Hospital. She was head of department of Paediatric Neurology until December 2020 when she stepped down from management functions to be able to concentrate again on patient care and research.  She has a wide interest in paediatric neurological topics but neuro-oncology and especially the neurocognitive sequelae of brain tumour treatment has always been her field of choice. Her first of many publication on the Cerebellar Mutism Syndrome dates from 1992.  She had or has multiple leadership positions: She served in the board of the Dutch Society of Paediatric Neurology from 1995 and from 2004-2010 as President. She was board member of the Posterior Fossa Society from  2014 and Chair of this Society from 2016-2018.  She has been an elected board member of the European Paediatric Neurology Society 2004 and Chair of the EPNS Education and Training Committee  since 2014. Since 2014 she is Chair of the Committee of National advisors to EPNS and the Training Advisory Board. In this role she took the lead in revision of the European training syllabus for paediatric neurologists and visited national training programmes in Spain and Georgia. Also she was responsible for the organization of multiple EPNS international training events in Budapest, Alicante, Cambridge, Tblisi, Astana and Tashkent. She was member of the organising Committee of the International Child Neurology Congress in Amsterdam in 2016,. She is member of the advisory boards of the Dutch Neurofibromatosis Society and the Society of patients with Sturge Weber Syndrome and member of various Dutch multidisciplinary professional networks that support  organisations of patients with Acquired Brain Injury.

A native of Iceland, Dr. Gudrunardottir studied medicine in Copenhagen, Denmark. She started researching cerebellar mutism already as a medical student, and is the primary author of the protocol for the Nordic/European Study of Cerebellar Mutism Syndrome in Children with Brain Tumours of the Posterior Fossa that currently runs in 20 centers across Europe and Scandinavia. She took the initiative to forming the Posterior Fossa Society in 2014, was the society’s first president from 2014-2016, hosted its two consensus meetings in Reykjavik in 2015 and 2018 and drove the Delphi procedures by which a new definition of “pediatric post-operative cerebellar mutism syndrome” was formed in 2016. Dr. Gudrunardottir divides her time between working as a GP and emergency physician in rural Norway and doing research in Copenhagen, where her main focus is currently on doctors’ health. If she has not responded to your query yet she is probably out fishing. 

Andrew Lux a Consultant Paediatric Neurologist at Bristol Royal Hospital for Children, Bristol, UK. He graduated from Nottingham University Medical School and then trained in General Practice, Paediatrics and Paediatric Neurology in Hull, Cardiff, Bath and Bristol. He worked as a general paediatrician in St Lucia, West Indies for three years, and spent one year training in Pediatric Epilepsy and Clinical Neurophysiology at St Louis Children’s Hospital, St Louis, Missouri, USA. He has an MSc in Medical Statistics at the London School of Hygiene & Tropical Medicine, and a PhD from the University of Bath. He has contributed to Delphi processes as part of his PhD work and with the consensus statements of the Posterior Fossa Society, which he joined in 2014.   

Philippe Paquier is a full professor of psycholinguistics and neurolinguistics at the Vrije Universiteit Brussel, Brussels, and an associate professor of neurolinguistics and aphasiology at the Université Libre de Bruxelles, Brussels.  He was the former Chair of the Department of Clinical and Cognitive Neuropsychology at ULB-Erasme University Hospital, Brussels.  His primary research interests focus on pediatric neurological neurocognitive and speech/language disorders, with special emphasis on (a) the syndrome of cerebellar mutism and related disorders in children, (b) the long-term neurocognitive outcome of childhood brain tumor survivors, (c) epileptic encephalopathies with neurocognitive regression (continuous spikes and waves during slow sleep; Landau-Kleffner syndrome). 

Zoltan is a board-certified neurologist and radiologist with subspecialty qualification in neuroradiology and special expertise in pediatric neuroradiology. He trained in Hungary, France and Belgium and worked for 10 years in the King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia before moving to the USA. His interests in neuroradiology span over MR imaging of neurovascular disorders, neurometabolic diseases and brain tumors in children. Currently, he focuses on a.) Imaging genomics in embryonal tumors of the central nervous system (including medulloblastoma and ATRT). b.) Conventional as well as quantitative MR-based analysis of pediatric high-grade gliomas (diffuse midline gliomas, in particular), and c.) Early side effects of cancer treatment (including the phenomenon of diaschisis in the central nervous system and its clinical implications in cerebellar mutism syndrome). He has published more than 100 peer-reviewed papers and wrote or contributed to 20 book chapters published in major pediatric radiology textbooks. 

Barry is a Consultant Paediatric Oncologist at Alder Hey and Honorary Professorship at the University of Liverpool. He has a particular interest in Central Nervous System tumours and supportive care in children and young people. Barry has had a prominent place in the UK Children’s Cancer and Leukaemia Group (CCLG) and the International Society of Paediatric Oncology-Europe (SIOPE) and is a previous chair of both the CCLG and SIOPE  brain tumour groups.He has been Chief Investigator and had additional lead roles in several national and international clinical trials and in the production of several national guidelines for brain tumours and information guides for families of children with cancer.   He has been an  author on over 190 papers and book chapters.Barry was previously co-Director of research at Alder Hey and leads an expanding Liverpool based clinical and translational research programme. Barry is also strongly committed to International Child Heath.  In particular, he has developed strong links with the children’s cancer unit at Kanti Children’s Hospital, Kathmandu as well as several other overseas initiatives.  In 1997 he formed and Co-Chaired the CCLG Paediatric Oncology in Developing Countries Group.  In 2018 he became the first Director of the Alder Hey International Child Heath Group.

Darcy Raches Ph.D. is a pediatric neuropsychologist in the Section of Neuropsychology at St. Jude Children’s Research Hospital in Memphis, Tennessee. She provides neuropsychological assessment and consultation for children with hematological and oncological diagnoses and associated genetic predisposition syndromes, such as neurofibromatosis type 1 (NF1). Additionally, Dr. Raches is the lead neuropsychologist to the Acute Neurological Injury team, an interdisciplinary group of rehabilitation professionals and other medical providers at St. Jude. In this capacity she provides brief assessments, tracks cognitive progress and provides cognitive rehabilitation for children who have experienced an acute neurological injury related to their hematological/oncological diagnosis and/or treatment, particularly posterior fossa syndrome and stroke. Dr. Raches is actively involved in the education and mentorship of pre- and post-doctoral students at St. Jude and other institutions.  She is an active clinical researcher with a focus on the cognitive effects of cancer and cancer directed treatments and a special interest in posterior fossa syndrome/post-operative pediatric cerebellar mutism syndrome.

Sharyl is a Speech-Language Pathologist and an Associate Professor in the Department of Communication Sciences and Disorders at the University of Minnesota-Duluth. She earned her B.A.S. and M.A. in Communication Sciences and Disorders from the University of Minnesota-Duluth and her Ph.D. in Rehabilitation Science from the University of Minnesota-Twin Cities. She gained clinical experience in assessment and treatment of speech, language and cognitive deficits in children with a variety of neurologic conditions including Cerebellar Mutism Syndrome (CMS) at Children’s Hospitals and Clinics of Minnesota-St. Paul. Her research investigates neurological mechanisms associated with neuroplasticity of motor speech, language and cognition and novel interventions that harness non-invasive brain stimulation and behavioral intervention for optimal neural recovery. 

Jeffrey H. Wisoff, M.D., Professor of Neurosurgery and Pediatrics at the New York University School of Medicine and served as Director of the Division of Pediatric Neurosurgery at the Hassenfeld Children’s Hospital at New York University Langone Medical Center from 1996-2018.  During the past 30 years he has made major innovative contributions to the surgical treatment of neurological disorders in children and congenital problems in adults, in particular to the treatment of brain tumors, Chiari malformations, hydrocephalus and craniosynostosis.  He has published over 250 scientific articles, abstracts, and book chapters.Dr.Wisoff is the past Co-Chairman of the Neurosurgery Committee and a senior member of the Brain Tumor Strategy Committee of the national Children’s Oncology Group.  He is the past Chairman of the Joint Section of Pediatric Neurosurgery of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons and currently serves on the Executive Board of the Posterior Fossa Society.  He is a member of the American Society of Pediatric Neurosurgery and the International Society for Pediatric Neurosurgery.  He has served on the medical advisory board of several national and international scientific and charitable organisations and has on the editorial board of a number of distinguished journals.Dr Wisoff  has numerous honors in respect to his contribution to neurosurgery and  highly sought as an invited speaker throughout North America and worldwide.